Browse drugs

…S) complete remission at D/C (OR: 0.20, p=0.005) and persistent hydroxychloroquine use (OR: 0.28, p=0.031) protected against post-D/C renal flares…

… SLE, the social and spatial variability and also study and use hydroxychloroquine prescription patterns as an external validation for case ascert…

…(76%) on active treatment with corticosteroids, and 40 (80%) on hydroxychloroquine treatment. Twenty-six (52%) patients had positive anti-dsDNA an…

… high-dose corticosteroids, six sessions of plasmapheresis, and rituximab. Due to persistent pancytopenia with febrile neutropenia, empir…

…tion of potential offending agents such as MMF, fluoxetine, and hydroxychloroquine, and treatment with oral nimodipine, she developed a new left h…

…C 2021 criteria, while nine met ILE criteria. During follow-up, hydroxychloroquine was used in 14 patients, csDMARDs in 9, JAK inhibitors in 10, a…

…vity, Lupus nephritis. She was treated with Methylprednisolone, Hydroxychloroquine, Azathioprine, one infusion of Belimumab. After 18 month evolut…

… Due to therapeutic failure with rituximab, she was switched to anifrolumab. Twelve days after the first infusion, she developed a painful …

… refractory to multiple therapies, highlighting the response to rituximab. Prior reports support the benefit of rituximab in SLE-associat…

…tologic (lymphopenia), and serologic activity (SLEDAI-2K 6–8 on prednisolone 10 mg/day).Results In August 2024, anifrolumab 300 mg IV monthl…

…2% female; 96.0% Caucasian). At enrolment, 88.2% were receiving hydroxychloroquine (n=179). Overweight/obesity prevalence was 60.1%, and 83.3% had…

…26]), with median FACIT-Fatigue 32 (18–43). Corticosteroids and hydroxychloroquine were most frequently used (85.5% and 81.7%), followed by azathi…